These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9766857)

  • 21. Physicochemical factors associated with binding and retention of compounds in ocular melanin of rats: correlations using data from whole-body autoradiography and molecular modeling for multiple linear regression analyses.
    Zane PA; Brindle SD; Gause DO; O'Buck AJ; Raghavan PR; Tripp SL
    Pharm Res; 1990 Sep; 7(9):935-41. PubMed ID: 2235893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development and characterization of protein-based stationary phases for studying drug-protein and protein-protein interactions.
    Sanghvi M; Moaddel R; Wainer IW
    J Chromatogr A; 2011 Dec; 1218(49):8791-8. PubMed ID: 21704318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On-column entrapment of alpha1-acid glycoprotein for studies of drug-protein binding by high-performance affinity chromatography.
    Anguizola J; Bi C; Koke M; Jackson A; Hage DS
    Anal Bioanal Chem; 2016 Aug; 408(21):5745-5756. PubMed ID: 27289464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the melanin affinity of selegiline (deprenyl) and other amphetamine derivatives.
    Báthory G; Szüts T; Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):195-201. PubMed ID: 3124086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal pigment epithelium melanin and ocular toxicity.
    Dayhaw-Barker P
    Int J Toxicol; 2002; 21(6):451-4. PubMed ID: 12537641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding characteristics of drugs to synthetic levodopa melanin.
    Shimada K; Baweja R; Sokoloski T; Patil PN
    J Pharm Sci; 1976 Jul; 65(7):1057-60. PubMed ID: 957112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical approach on the conservation of drug molecules during hair fiber formation.
    Pötsch L; Skopp G; Moeller MR
    Forensic Sci Int; 1997 Jan; 84(1-3):25-35. PubMed ID: 9042707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New mathematical approach for the evaluation of drug binding to human serum albumin by high-performance liquid affinity chromatography.
    Zhivkova Z; Russeva V
    J Chromatogr B Biomed Sci Appl; 1998 Apr; 707(1-2):143-9. PubMed ID: 9613943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel bis(5-methyltetrazolium)amine ligand-bonded stationary phase with reduced leakage of metal ions in immobilized metal affinity chromatography of proteins.
    Bo C; Wang C; Wei Y
    Anal Bioanal Chem; 2016 Nov; 408(27):7595-7605. PubMed ID: 27580602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using α1-acid glycoprotein microcolumns.
    Bi C; Zheng X; Hage DS
    J Chromatogr A; 2016 Feb; 1432():49-57. PubMed ID: 26797422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity chromatography: a review of clinical applications.
    Hage DS
    Clin Chem; 1999 May; 45(5):593-615. PubMed ID: 10222345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling.
    Schiel JE; Ohnmacht CM; Hage DS
    Anal Chem; 2009 Jun; 81(11):4320-33. PubMed ID: 19422253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention data from affinity high-performance liquid chromatography in view of chemometrics.
    Kaliszan R
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):229-44. PubMed ID: 9792513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Entrapment of alpha1-acid glycoprotein in high-performance affinity columns for drug-protein binding studies.
    Bi C; Jackson A; Vargas-Badilla J; Li R; Rada G; Anguizola J; Pfaunmiller E; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():188-196. PubMed ID: 26627938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation procedures used to reveal and follow drug-protein binding.
    Sebille B; Zini R; Madjar CV; Thuaud N; Tillement JP
    J Chromatogr; 1990 Oct; 531():51-77. PubMed ID: 2258425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monolith weak affinity chromatography for μg-protein-ligand interaction study.
    Lecas L; Randon J; Berthod A; Dugas V; Demesmay C
    J Pharm Biomed Anal; 2019 Mar; 166():164-173. PubMed ID: 30654204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of [3H]flunitrazepam binding to melanin.
    Testorf MF; Kronstrand R; Svensson SP; Lundström I; Ahlner J
    Anal Biochem; 2001 Nov; 298(2):259-64. PubMed ID: 11700981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel column-based protein refolding strategy using dye-ligand affinity chromatography based on macroporous biomaterial.
    Li F; Dong PJ; Zhuang QF
    J Chromatogr A; 2009 May; 1216(20):4383-7. PubMed ID: 19344905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality improvements of cell membrane chromatographic column.
    Ding X; Chen X; Cao Y; Jia D; Wang D; Zhu Z; Zhang J; Hong Z; Chai Y
    J Chromatogr A; 2014 Sep; 1359():330-5. PubMed ID: 25115453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanin as an adsorbent for drug residues.
    Howells L; Godfrey M; Sauer MJ
    Analyst; 1994 Dec; 119(12):2691-3. PubMed ID: 7879877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.